Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

Two years ago, a researcher who specializes in the safety of breast milk was in the midst of breastfeeding her own child when she experienced a serious bout of postpartum depression. She had a televisit with her doctor, who refused to write her a prescription for antidepressant medications as long as she was still breastfeeding, even though the drugs are considered safe to take during pregnancy and breastfeeding.  “A lot of times, [the] health [of the new mother] isn’t prioritized as much as that of the infant. And that’s something that we really worry about,” says Kaytlin Krutsch, PharmD, a…

Read More

Taking too many medications raises your risk of adverse events. Deprescribing—the thoughtful process of identifying problematic medications and reducing the dose or stopping those medications in a safe, effective manner that  helps people maximize their well-being—is often easier said than done, explains Cynthia Boyd, MD, MPH, director of geriatric medicine and gerontology at Johns Hopkins University.  This is especially critical, if you have dementia or multiple chronic conditions. “There is relatively little research about how we actually deprescribe,” she says. “That speaks to the issue of how people end up on a whole bunch of medicines. It often is much…

Read More